Donepezil-associated bradyarrhythmia in a patient with dementia with lewy bodies (DLB)

Alzheimer Disease and Associated Disorders

Volumn 24, Issue 2, 2010, Pages 209-211

  Rosenbloom, Michael H ^a   Finley, Richard ^b   Scheinman, Melvin M ^c   Feldman, Mitchell D ^a   Miller, Bruce L ^a   Rabinovici, Gil D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Clinical Pharmacy ^*  (United States)

^c Cardiology Division   (United States)

Author keywords

Aricept; Dementia with Lewy bodies; Donepezil; Sympathetic deinnervation

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BRADYCARDIA; BRAIN DYSFUNCTION; CARDIOVASCULAR RISK; CASE REPORT; CELL LOSS; CHOLINERGIC NERVE CELL; DIFFUSE LEWY BODY DISEASE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FACIAL EXPRESSION; FALLING; GAIT DISORDER; HEART RATE; HUMAN; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRESCRIPTION; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; VISUAL IMPAIRMENT;

AGED; BRADYCARDIA; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDANS; LEWY BODY DISEASE; MALE; PIPERIDINES;

EID: 77953272427     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3181b7642b     Document Type: Article

References (10)

1. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872.
2. Simard M, van Reekum R. The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci. 2004;16:409-425.
3. Thomas AJ, Burn DJ, Rowan EN, et al. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. Int J Geriatr Psychiatry. 2005;20:938-944.
4. Watanabe H, Ieda T, Katayama T, et al. Cardiac (123) I- metaiodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001;70:781-783.
5. Darvesh S, Arora RC, Martin E, et al. Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons. Exp Neurol. 2004;188:461-470.
6. Shepherd G, Klein-Schwartz W, Edwards R. Donepezil overdose: a tenfold dosing error. Ann Pharmacother. 1999;33:812-815.
7. Calvo-Romero JM, Ramos-Salado JL. Symptomatic sinus bradycardia associated with donepezil. Rev Neurol. 1999;28:1070-1072.
8. Suleyman T, Tevfik P, Abdulkadir G, et al. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil. Emerg Med J. 2006;23:641-642.
9. Bordier P, Garrique S, Barold SS, et al. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors. Europace. 2003;5:429-431.
10. Ballard C, Lane R, Barone P, et al. Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias. Int J Clin Pract. 2006;60:639-645.